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Introduction
Catechol-O-methyltransferase (COMT) is a widely expressed enzyme responsible for the O-
methylation and deactivation of catechol-containing compounds, including epinephrine, 
norepinephrine, and dopamine [21]. Hence, COMT is an important regulator of extracellular 
concentrations of key neurotransmitters involved in numerous neurological functions, 
including pain perception. Despite being extensively influenced by environmental factors, 
the genetic component of pain is substantial and its heritability ranges from 22–60% [29, 
30]. COMT is currently one of the most studied genes in pain genetics research [23], due to 
its critical involvement in pain transmission pathways.
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The COMT gene carries many common single nucleotide polymorphisms (SNPs) along its 
sequence. The most investigated single SNP is rs4680 (val158met) [19], whose met allele is 
associated with greater pain sensitivity [44]. This SNP is also integrated into one of the three 
major functional COMT haplotypes initially identified by our study group [9], together with 
SNPs rs6269 and rs4633, and rs4818. The most frequently occurring haplotype, consisting 
of alleles ATCA (48.7%), is associated with intermediate pain responsiveness and named 
APS for average pain sensitivity. The second most frequent (GCGG, 36.5%) haplotype is 
associated with lowest pain responsiveness and named LPS (low pain sensitivity). The least 
frequent haplotype (ACCG, 10.5%) is associated with highest responsiveness to pain and 
named HPS (high pain sensitivity) [9]. Similar frequencies of COMT haplotypes and their 
contribution to different pain-related phenotypes have also been reported in other studies 
[14, 22, 31, 40, 42]. Although the molecular genetic mechanisms whereby the APS and HPS 
haplotypes regulate COMT activity are different [19, 27], both encode reduced enzymatic 
activity compared to LPS. Subsequently, elevated levels of epinephrine activating beta 
adrenergic receptors was demonstrated as the mechanism whereby reduced COMT activity 
leads to exacerbated pain perception [28].
Numerous studies have investigated the association between COMT genetic variants and 
multiple pain phenotypes, but results have not always been consistent [39]. Among many 
non-genetic reasons that may account for this lack of consistency and have been discussed 
elsewhere [2], genetic effects are often modified by interactions with environment and sex, 
especially for genetic variants of substantial minor allele frequency and modest effect size 
[24].
Among environmental factors, exposure to stress and its consequent release of epinephrine 
[10, 38] is likely to affect the same pain pathways as COMT [28]. Additionally, COMT is 
less expressed in females [5, 7, 21, 35, 43], which may account for its sexually dimorphic 
effects [3, 16, 34]. We thus hypothesized that the relationship between common functional 
COMT genetic variants, such as the COMT haplotypes, and pain would be greatly influenced 
by stress and sex. We therefore investigated if COMT haplotypes, stress, and sex interact to 
modify sensitivity to various pain modalities ranging from experimental pain to clinical 
acute pain.
Material and Methods
Phenotypic data were obtained from two independent multicenter cohorts fully described 
elsewhere [20, 32, 36] and briefly described here. Approvals of the institutional review 
boards were obtained from each of the sites and data-coordinating centers participating in 
the OPPERA (Orofacial Pain: Prospective Evaluation and Risk Assessment) and in the post-
MVC (motor vehicle collision) studies. All subjects participating in both studies provided 
signed informed consent.
OPPERA: study setting and participants
The OPPERA cohort consists of males and female study volunteers from multiple ethnicities 
and aged between 18 to 44 years who were enrolled at four U.S. study sites. It was primarily 
designed to identify determinants of temporomandibular disorders (TMD) [20]. Between 
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May 2006 and November 2008, subjects from Baltimore (MD), Buffalo (NY), Chapel Hill 
(NC), and Gainesville (FL) were recruited to participate in the study by advertisements, e-
mails, flyers, and word of mouth. In total, 3,263 TMD-free controls and 185 chronic TMD 
cases were enrolled. Detailed demographic description of the full cohort has been previously 
reported [36]. After removing participants who were missing genetic data or other critical 
phenotypic data, 2,972 were considered eligible for this study. The mean age of the included 
study subjects was 26.9 years, consisting in 1,274 (42.9%) males and 1,698 (57.1%) 
females. The cohort is racially diverse, with 1,578 (53.1%) non-Hispanic white subjects, 845 
(28.4%) African-Americans, 259 (8.7%) Asians, 203 (6.8%) Hispanics, and 87 (2.9%) 
subjects of other or mixed races.
OPPERA: phenotype collection
In this cohort, subjects completed a 3-hour clinic visit that included questionnaires, blood 
sample collection, clinical examination, quantitative sensory testing (QST) and measures of 
blood pressure, heart rate and heart rate variability, the latter done at rest and following 
orthostatic and psychological challenge. Since measures of response to repeated thermal 
stimuli provide the strongest association with COMT haplotypes [3, 8], we focused on these 
measures in the present study.
A detailed description of the QST procedures have been provided elsewhere [15]. Briefly, 
thermal pain sensitivity was assessed using a commercially available thermal stimulator 
(Pathway; Medoc; Ramat Yishai, Israel). Prior to testing, subjects were instructed to 
verbally rate their peak pain intensity after each pulse using a 0–100 numerical scale, where 
“0” represented “no pain” and “100” represented “the most intense pain imaginable”. 
Participants were also told that they would receive a series of 10 pain-evoking thermal 
stimuli in a row, and would be asked to report their peak pain intensity after each stimulus. 
Practice trials were administered to provide the participant a sense of the timing of stimulus 
delivery and to verify understanding of the protocol. The thermode (5.73 cm2) was manually 
placed on the skin of the ventral forearm at a temperature of 38°C, and 10 temperature 
pulses were given at 2.4 to 2.5 second inter-stimulus intervals. For the first series of stimuli, 
the peak temperature was 46°C, with a ramp rate of 20°C/second, and a hold time of 750 
msec at the peak temperature. Following this, the thermode was moved to another location 
on the forearm, and the same protocol was conducted with a peak temperature of 48°C. This 
was followed by another test series with a 50°C peak temperature at a third location. For 
each temperature, a total of ten response measures to repeated thermal stimuli were 
collected. The data were used to compute three analytic variables: first pulse, defined as the 
peak pain intensity to the first of 10 thermal pulses at each of the three temperatures; area 
under the curve (AUC), defined as the overall responsiveness to the 10 repeated thermal 
stimuli within each of the series; and maximum pain, defined as the highest peak pain 
intensity reported by the subject during each of the three series of stimuli (Supplementary 
Figure 1).
After the pain sensitivity tests, a cognitive test (STROOPx2) challenging subjects to name 
the color of a word that is printed in a different color (e.g., the word "red" printed in blue, in 
which case “blue” would be the correct answer) was conducted. At the end of this, subjects 
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were asked to rate how stressful they found the entire experimental session to be using a 0–
100 numerical rating scale (NRS) where “0” represented “not at all stressful” and “100” 
represented “extremely stressful”. The NRS value indicated by the subject was used as the 
measure of stress in this study, since it was the stress assessment carried out closest in time 
to the QST session and most importantly, we trust that it best represents the subject’s global 
stress level during the entire QST session.
OPPERA: genotyping
Genomic DNA was purified from blood samples using Qiagen Extraction Kits from 
Cogenics, Inc (now Integrated Laboratory Systems, Morrisville, NC). Genotypic data were 
obtained using the Pain Research Panel (Algynomics, Chapel Hill, NC), a chip-based 
platform that consists of 3,295 SNPs representing 358 genes known to be involved in 
systems relevant to pain perception [37]. COMT SNPs rs6269 and rs4818, and SNPs rs4633 
and rs4680, are in complete linkage disequilibrium (LD) in the Caucasian population. In the 
Pain Research Panel, SNPs rs6269 and rs4633 tag SNPs rs4818 and rs4680, respectively, 
and were thus used for COMT haplotypes reconstruction using HaploView [1].
Post-MVC: study setting and participants
The post-MVC study is a prospective multicenter cohort of 948 European American males 
and females aged 18 to 65 years [32]. The primary goal of this study was to gain new 
insights into the pathophysiology of persistent pain and psychological sequelae after minor 
MVC. Individuals presenting to one of the participating research network emergency 
department (ED) sites within 24 hours after a minor MVC were recruited. Participating sites 
included the Baystate Medical Center, Massachusetts General Hospital, North Shore 
University Hospital, Shands Jacksonville Hospital, Spectrum Health Butterworth Hospital, 
St. Joseph Mercy Hospital, and William Beaumont Hospital (2 sites). A research assistant 
stationed in each of the eight study site EDs approached potentially eligible patients and 
they were asked to participate in the study after the voluntary nature of their participation, 
risks and benefits of the study had been explained. Following consent, study participants 
completed study procedures described below. From the 10,629 individuals who presented to 
the ED within 24 hours after a minor MVC, 1,416 were considered eligible, 969 agreed to 
participate in the study, and 948 completed the evaluation. The mean age of study 
participants was 36 years, of which 575 (61%) were females and 373 (39%) were males.
Post-MVC: phenotype collection
For this study, we focused on two phenotypes collected within 24 hours after the MVC: pain 
intensity, defined as the overall pain intensity at the time of evaluation, and distress level, as 
determined by the Peritraumatic Distress Inventory [6]. Current pain intensity was assessed 
using a numeric rating scale (NRS) ranging from 0 (‘no pain’) to 10 (‘worst pain possible’). 
If the participants reported pain, they were also asked whether the pain was related to the 
MVC; only MVC-related pain (greater than 99% of all pain reported) was included in the 
present analyses. Peritraumatic distress (score range from 0 to 52) was assessed using the 
Peritraumatic Distress Inventory (PDI). The PDI is a reliable and valid instrument for 
measuring distress during the peritraumatic period [6, 41].
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Post-MVC: genotyping
Blood (8.5cc) was collected using PAXgene DNA storage tubes. Blood samples were then 
refrigerated at the study site and shipped in batches every 2 weeks to Beckman Coulter 
Genomics, Inc, Morrisville, NC. DNA purification was performed using the PAXgene™ 
blood DNA kit (Qiagen, Valencia, CA). Genotyping was performed in batches using the 
Sequenom platform (Sequenom, Inc., San Diego, CA). The LD between COMT SNPs was 
explored by calculating Levontin D’ and squared correlation r2 using HaploView [1]. 
Haploblocks were estimated using the method of confidence intervals [12]. COMT 
haplotypes and their population frequencies were estimated using the expectation-
maximization algorithm implemented in HaploView and were then verified using Bayesian 
estimation of haplotype frequencies implemented in HAPLOTYPE procedure (SAS version 
9.2, SAS Institute, Cary, NC) [18]. Detailed linkage disequilibrium and haplotype structure 
of COMT in this cohort have been reported elsewhere [4], and corresponded to those 
identified in the discovery OPPERA cohort and in the original publication [9].
Data analysis
The association between pain sensitivity and COMT haplotype, stress, and sex in the 
OPPERA cohort was evaluated using regression models. Given that the COMT haplotypes 
affect pain sensitivity in both healthy control and TMD-case subjects, both control and 
TMD-case subjects were included in the analysis. The outcome variable in each model was 
one of the measures of thermal pain sensitivity (first pulse, AUC, or maximum pulse at 
46°C, 48°C, or 50°C). Prior to fitting the model, each outcome variable was normalized to 
have mean 0 and standard deviation 1 to ensure that regression coefficients for the different 
outcomes had comparable scales. Predictors in the model included a dummy variable for 
female sex, a dummy variable for study site, the participant’s self-reported stress rating, and 
dummy variables for the number of APS or HPS haplotypes carried by each participant. The 
LPS haplotype was treated as the reference group, so the count of LPS haplotypes was not 
included in the model. All two-way and three-way interactions were also included in the 
model. To control for the effects of population stratification due to racial heterogeneity in 
the OPPERA cohort, ancestral eigenvectors were computed for each OPPERA participant 
using the Eigenstrat software [33]. The first six eigenvectors were included as covariates in 
the model. Inverse probability weighting was used to adjust for the case-control study design 
(which caused chronic TMD cases to be overrepresented in our sample). Variance estimates 
were computed using weighted generalized estimating equations to compute the sandwich 
estimator of the variance [26]. The prevalence of chronic TMD in the population was 
assumed to be 5% [17]. The threshold of statistical significance was set at P=0.05. The 
finding was further highlighted when P<0.006, because it is consistent with a strict 
Bonferroni correction for tests of nine thermal pain measures. However, this degree of 
correction is overly cautious, given that the nine measures were correlated. Later, this 
analysis was repeated using only the count of HPS haplotypes in the model (APS was not 
included). In other words, the second series of models included the count of HPS haplotypes 
as a predictor variable but not the count of APS haplotypes. Considering that TMD-case 
subjects are more likely to be female and to carry the HPS haplotype, which may not be 
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sufficiently controlled for by inverse probability weighting, another series of models using 
only the count of HPS haplotypes and control subjects was conducted.
The predicted values of the second series of models were plotted against the count of HPS 
haplotypes. Three fixed values of self-reported stress were considered, namely 0, 10, and 20 
(the latter two values corresponding roughly to the 50th and 75th percentile of the 
distribution of self-reported stress), and the predicted values were calculated separately for 
males and females and for each of the two values of stress. When calculating these predicted 
values, the study site was assumed to be North Carolina and the values of all six ancestral 
eigenvectors were set to be 0. Each pain measure was also plotted against self-reported 
stress separately for those with 0, 1, or 2 copies of the HPS haplotype, and a loess curve was 
calculated and plotted to visualize the association between stress and pain. The analysis was 
also repeated separately for males and females.
A final set of models repeated the analysis separately for males and females but treated 
stress as a dichotomous variable. Rather than using the 0–100 self-reported stress rating as a 
covariate, this covariate was replaced with a dummy variable that was equal to 1 if the 
participant reported any stress during the procedure (i.e., a stress rating of greater than 0) 
and 0 otherwise. Contrasts were used to evaluate the effect of the HPS haplotype in both the 
“stressed” and “non-stressed” groups.
The associations between COMT haplotypes and pain outcomes in the post-MVC cohort 
were assessed using general linear models. Study site was included in these models as a set 
of dummy variables to account for potential genetic heterogeneity between study 
recruitment centers. Interactions between COMT haplotypes, peritraumatic distress, and 
patient sex on acute pain severity were assessed by introducing the corresponding product 
terms into the model. Significance of the model parameter estimates was evaluated using the 
t-statistic. In order to evaluate the stability of the interaction estimate, we re-fitted the model 
in 1000 bootstrap samples, and output the 95% confidence intervals for the interaction term 
estimate.
Results
OPPERA cohort: experimental thermal pain sensitivity
Data for this study were collected from 2,972 female and male subjects who were enrolled 
in the OPPERA cohort. In the present study, we have investigated if the effect of COMT 
haplotypes on pain sensitivity can be modified by interactions with stress and sex, by means 
of a three-way interaction analysis. The distribution of study subjects according to sex, stress 
level, and COMT haplotypes can be found in Table 1. Because thermal pain, especially 
measures of response to repeated thermal stimuli, is the sensory domain most strongly 
associated with COMT haplotypes [3, 8], different measures of response to repeated thermal 
stimuli were tested (Supplementary Figure 1). This analysis was conducted with all three 
COMT haplotypes in the model (LPS, APS, and HPS), using the LPS haplotype and male 
sex as reference haplotype and sex, respectively. Subjects’ ratings of how stressful they 
found the entire QST session to be was used as the stress measure, since it was the closest 
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stress assessment to the thermal pain sensitivity procedures. The median stress score was 10, 
the interquartile range went from 1–20, and 24.5% of subjects reported a score of zero.
In the OPPERA cohort, the three-way interaction was not significant for any of the measures 
of thermal pain sensitivity tested (Supplementary Table 1). Nonetheless, the two-way 
interaction between HPS haplotype and stress was significant for all temperatures of the 
“AUC” and “maximum pain” measures, such that the effect of stress on pain decreased as 
the number of HPS haplotypes increased (Table 2). Four of these interactions were 
significant even after strict Bonferroni correction (P<0.006). Two-way interactions between 
APS haplotype and stress, between APS or HPS haplotype and sex, and between stress and 
sex were not significant for any of the measures of thermal pain sensitivity tested (Table 2). 
Additionally, the main effects of stress and sex, but not COMT haplotypes, were associated 
with all measures of thermal pain sensitivity tested, with stress and female sex being 
significantly associated with increased thermal pain sensitivity (Table 2).
Because neither the main effect of APS haplotype nor any of its interactions were 
statistically significant, a new analysis was conducted excluding the APS haplotype from the 
model, and focusing on the count of HPS haplotype. The two-way interaction between HPS 
haplotype and stress was statistically significant for all temperatures of the “AUC” and 
“maximum pain” measures, such that presence of the HPS haplotype conferred a weaker 
association between stress levels and pain (Table 3). Virtually the same results were 
obtained when only control subjects were included in the analysis (Supplementary Table 2). 
Thus, in order to increase the power of generalization of our study, all subsequent analyses 
were done including both controls and TMD cases. The weakening effect of the HPS 
haplotype on the association between stress levels and pain is illustrated in Supplementary 
Figure 2, which displays the relationship between pain sensitivity and stress in individuals 
carrying 0, 1, or 2 copies of the HPS haplotype for one representative measure of thermal 
pain sensitivity (AUC at 48°C). The relationship between thermal pain sensitivity and stress 
in individuals carrying no copies of this haplotype was characterized by a steep slope, in 
which thermal pain sensitivity increased with the increased report of stress. This slope 
though became gradually flatter as the number of copies of the HPS haplotype increased. 
Additionally, the two-way interaction between stress and sex was significant for “AUC” and 
“maximum pain” at 50°C, such that the association between stress and pain was weaker for 
females compared to males (Table 3). The two-way interaction between HPS haplotype and 
sex was not statistically significant for any of the measures of thermal pain sensitivity tested 
(Table 3). Also, the main effect of the HPS haplotype was statistically significant at virtually 
all temperatures for the “AUC” and “maximum pain” measures. HPS haplotype count, stress, 
and female sex were associated with higher thermal pain sensitivity (Table 3).
Results of the analysis including only the HPS haplotype in the model also suggested that 
the main effects of stress and female sex, both contributing to increased thermal pain 
sensitivity, may be superseded by the interaction between them. This finding needs to be 
interpreted with caution because the interaction effects were seen for the measures of “AUC” 
and “maximum pain” at 50°C. Since stress and female sex are independently associated with 
higher thermal pain sensitivity, it might be that at 50°C, the highest temperature used in the 
QST procedures, females reporting stress reach the plateau of their pain sensitivity quicker 
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than males not reporting stress. Consequently, the increasing effect of stress on pain 
sensitivity of females becomes lower possibly due to ceiling effects, as denoted by the effect 
of the two-way interaction between stress and gender for “AUC” and “maximum pain” at 
50°C (Table 3).
Finally, we dichotomized our research subjects by their report of stress and compared the 
effect of the HPS haplotype on thermal pain sensitivity in individuals who reported no stress 
to individuals who reported any stress for each sex separately (Supplementary Table 3). 
These results showed that in females or males reporting no stress, there was a strong dose-
dependent effect of the HPS haplotype, in which each additional copy of the haplotype was 
associated with higher pain sensitivity for all measures of thermal pain sensitivity tested 
(solid lines, Figure 1 and Supplementary Figure 3). This association, however, was absent in 
females or males reporting any stress, and its increasing effect on pain sensitivity leading to 
such a loss of effect is also shown in Figure 1 and Supplementary Figure 3. Figure 1 also 
illustrates that females are generally more sensitive to thermal pain, as denoted by the 
upward lift in the thermal pain sensitivity curve of females compared to that of males.
Altogether, results of the analyses performed for experimental thermal pain sensitivity 
indicate that HPS haplotype, stress, and sex contribute to pain sensitivity and their main 
effects may be further modified by interactions between them. Specifically, the effect of 
stress on pain sensitivity is modified by its interaction with the HPS haplotype, so that the 
increasing effect of stress on pain decreases as the number of copies of the HPS haplotype 
increases. Additionally, even though the effect of this interaction shows no difference 
between sexes, the response curves of females and males are shifted relative to each other 
due to the higher general pain sensitivity of females. With these results in mind, we then 
tested the effect the interaction among HPS haplotype, stress, and sex on an independent 
cohort of individuals with clinical acute pain.
Post-MVC cohort: clinical acute pain
For this study, data were collected from 948 female and male subjects enrolled in the post-
MVC cohort. Here, we tested the effect of the interaction among HPS haplotype, stress, and 
sex on clinical acute pain severity. The distribution of study subjects according to sex, stress 
level, and COMT haplotypes can be found in Table 4. Clinical acute pain severity was 
defined as the rating of subjects of their overall pain intensity (0–10 NRS) when presenting 
at the ED. Analysis was done including only the HPS haplotype in the model, and using 
males as the reference sex. It included a set of dummy variables for study site, to adjust for 
potential heterogeneity of the study population between sites. Peritraumatic distress was 
included in the model as the Peritraumatic Distress Inventory (PDI) total score. The median 
PDI score was 18, the interquartile ranged from 12–26, the minimum value was of 0 and 
maximum of 48, and 1.5% of subjects reported a score of zero.
This analysis revealed that the effect of the three-way interaction among HPS haplotype, 
stress, and sex on clinical acute pain severity was statistically significant (p=0.0097, Table 5, 
Model 1). In order to clarify how HPS haplotype, sex, and stress interact to modify clinical 
acute pain sensitivity, we tested the effect of the interaction between HPS haplotype and 
stress on females and males separately (Models 2–3, Table 5). We observed that the effect of 
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the HPS haplotype on pain sensitivity was modified by stress in males only, as denoted by 
the significant interaction between HPS haplotype and stress in males (p=0.013), but not in 
females (p=0.484).
We then dichotomized the peritraumatic distress score into high distress (PDI score > 18) 
and low distress (PDI score ≤ 18) and compared the effect of the count of HPS haplotype on 
pain sensitivity in males with low distress, males with high distress, females with low 
distress and females with high distress (Table 5, Models 4–7). This analysis demonstrated a 
significant effect of the HPS haplotype on acute pain severity only in males with low stress 
(p = 0.008). In this group, we observed a 1.2-point increase in pain severity per each copy of 
the HPS haplotype. This effect is illustrated in Figure 2, which shows a significant dose-
dependent effect of the HPS haplotype on pain sensitivity among males with low stress only; 
the effect of HPS haplotype is absent in males with high stress and in females with both low 
and high stress. Finally, we evaluated the association between distress (treated as a 
continuous PDI score) and pain severity separately in males and females carrying zero vs 1 
or 2 HPS haplotypes. We observed no association between distress and pain in males with 
one or two copies of HPS haplotype (regression coefficient beta = 0.007, SE = 0.048; p = 
0.88) and a strong positive association in males without HPS haplotype (beta = 0.076; SE = 
0.014; p < 0.0001). In females, the association between distress and pain severity was 
significant and was not affected by the presence or absence of HPS haplotype (beta = 0.077, 
SE = 0.023, p = 0.001 in females with 1 or 2 copies of HPS haplotype; beta = 0.054, SE = 
0.012, p < 0.001 in females with no HPS haplotypes).
Overall, similar to what was observed in the OPPERA cohort relative to experimental 
thermal pain sensitivity, analyses of this clinical acute pain cohort demonstrate that HPS 
haplotype, stress, and sex contribute to acute pain after MVC. Specifically, the effect of 
stress on pain sensitivity is modified by its interaction with the HPS haplotype and sex, so 
that the increasing effect of stress on pain report decreases as the number of copies of the 
HPS haplotype increases in males but, unlike what was observed in the OPPERA cohort, 
virtually absent in females.
Discussion
Results obtained for both the experimental thermal pain and clinical acute pain studies 
demonstrate that HPS haplotype, stress, and sex interact with each other and modify pain 
sensitivity. Based on our results, we suggest that stress and sex may impact the ability to 
detect COMT-dependent pain sensitivity due to their effects on the adrenergic system. 
Specifically, because low COMT activity (HPS haplotype) and exposure to stress can 
increase the epinephrine load in the system, an increase to pain sensitivity may also result. 
This relationship, however, may reach a plateau under a wide range of physiological 
conditions. This suggests that COMT-dependent pain sensitivity can be ideally observed in 
states in which this relationship has not yet reached such a plateau, making the detection of 
this association somewhat dependent upon factors that can affect this relationship. 
Inferences based on our results are summarized on Figure 3.
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Based on our findings, stress is one of the key factors producing such an effect, and 
therefore, impeding the ability to detect the HPS haplotype contribution to pain sensitivity. 
Because exposure to stress leads to a tonic increase in the release of epinephrine [38], it 
contributes to enhancement of adrenergic system activity, thereby increasing the epinephrine 
load in the system in proportion to the intensity of the stressor event. In our study, the 
stressor event in the OPPERA cohort was the quantitative sensory testing (QST) session 
itself, which is likely to produce a lower stress response (i.e., release of epinephrine) than a 
motor vehicle collision. Consequently, if the exposure to stress is strong enough to saturate 
the adrenergic system, the association between the HPS haplotype and pain sensitivity will 
no longer be observable. Indeed, our findings show no significant association between the 
HPS haplotype and pain sensitivity in subjects under stress in both the OPPERA and post-
MVC cohorts (Figure 3, OPPERA-any stress and post-MVC-high stress lines). Interestingly, 
experimental pain testing has been reported before as a stressful factor, masking genetic 
association results [25].
Another factor that may impact the detection of COMT-dependent pain sensitivity is sex, as 
indicated by the significant interaction among HPS haplotype, stress, and sex in the post-
MVC cohort. Females are known to express less COMT due to estrogenic down-regulation 
[5, 7, 21, 35, 43], and thus to exhibit higher baseline COMT-dependent pain sensitivity. 
Consequently, at the same epinephrine level, females should show higher pain sensitivity 
than males (Figure 3). This means that pain sensitivity would reach its plateau faster in 
females and thus, the association between the HPS haplotype and pain sensitivity would no 
longer be observable at lower levels of epinephrine in females compared to males. Indeed, 
our findings demonstrate no significant association between the HPS haplotype and pain 
sensitivity even in females categorized as low stress, but exposed to a strong stressor event, 
as in the post-MVC cohort (Figure 3, post-MVC-low stress line). On the other hand, for 
females in the OPPERA cohort, pain sensitivity was likely still within the linear range of its 
relationship with epinephrine load. As a result, the effect of the HPS haplotype on pain 
sensitivity was still detectable (Figure 3, OPPERA-no stress line).
Our findings suggest that both the HPS haplotype and stress, the former coding for low 
COMT activity and the latter leading to release of epinephrine, may contribute to 
augmenting the epinephrine load in the system and thus, to heighten pain sensitivity. 
Consequently, the association between the HPS haplotype and pain sensitivity would be 
more easily observed if the adrenergic system has not yet been overloaded with epinephrine. 
Otherwise, COMT-dependent pain sensitivity may have already reached its plateau, masking 
the contribution of the HPS to pain phenotypes. In light of these observations, we believe 
that it is important to maintain the stress level at minimum or to control for stress level when 
investigating the association between the HPS haplotype and pain phenotypes.
Furthermore, the present findings indicate that controlling for stress may be even more 
critical for the detection of the association between the HPS haplotype and pain sensitivity 
in females, as the relationship between epinephrine load and pain sensitivity may plateau 
faster than in males. This means that, in case of an increase in the epinephrine load, the 
association between the HPS haplotype and pain sensitivity would be masked faster in 
females, potentially obfuscating associations between COMT genetic variants and pain 
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phenotypes. Thus, we believe that it is also crucial to separate females from males or to 
adjust for gender when investigating the association between the HPS haplotype and pain 
phenotypes.
Such stress and sex-dependent effects are not unique to the COMT gene. For instance, SNP 
rs10877969 in the vasopressin-1A receptor gene (V1AR) has been shown to influence 
capsaicin pain levels exclusively in male subjects reporting stress. Subsequent experiments 
in mice confirmed this male-specific interaction of V1AR and stress, and demonstrated that 
vasopressin activates endogenous analgesia mechanisms unless they have already been 
activated by stress [25].
It should be noted that the stress measures used both in the OPPERA and post-MVC cohorts 
are not identical, nor are they pure measures of stress. In the OPPERA cohort, psychological 
stress was measured at the end of the entire QST session and was operationalized by 
subjects’ numerical ratings of how stressful they found that session to be. It is uncertain how 
much of this rating is accounted by the subjects’ stress response to the the pain experienced 
during the QST session or the challenge experienced during the end-of-the-session cognitive 
test. Considering that subjects had never experienced a QST session before, it is conceivable 
that they might be feeling stressed in response to the instructions to the QST session and fear 
of the upcoming pain-evoking stimuli. In fact, in a similar experimental noxious stimuli test 
for vasopressin agonist responses to capsaicin-induced pain, subjects expressed much higher 
stress response in the first testing session than in the second one [25]. In the post-MVC 
cohort, stress was measured using the Peritraumatic Distress Inventory, in which subjects 
rate the extent to which items such as life threat, loss of control, helplessness/anger were 
experienced during and immediately after the MVC. The questionnaire was administered to 
the subjects in the ED, that is, at the same time they were asked to rate their overall pain 
intensity. Hence, it is also uncertain how much of the stress score is accounted by the 
stressfulness of the MVC versus the stress triggered by MVC-related pain. However, even if 
these stress measures are not ideal, we believe that they are, at least in part, a function of the 
subjects’ underlying stress reactivity. Additionally, because the primary goal of both cohorts 
was not to investigate the causal relationship between pain and stress, their designs do not 
allow us to make conclusions regarding the directionality of effects. That is, although pain 
was the outcome variable in our regression models, it is equally plausible that pain may 
cause stress.
Few recent studies have provided evidence that COMT genetic variants interact with other 
psychological phenotypes that potentially have a stress reactivity component. The HPS 
haplotype was shown to be a robust predictor of persistent shoulder pain when combined 
with pain catastrophizing [13, 14]. In another study, the COMT met allele interacted with 
pain catastrophizing to produce more pain on days when pain catastrophizing was higher 
[11]. In these studies low activity COMT variants were additive to catastrophizing, which 
may reflect the fact that the measures were related to trait rather than state stress reactivity. 
The interaction between COMT genotypes and catastrophizing reinforce the importance of 
epinephrine load for pathophysiology of pain states.
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Finally, we propose that the presented gene (COMT) – environment (stress) – sex 
relationship deepens the current understanding of the pathophysiology of the COMT 
contribution to pain phenotypes. Clinically, we believe that combined – COMT haplotype, 
stress level, and sex – may represent an important risk factor contributing to heighten pain 
sensitivity in different pain conditions.
In conclusion, our findings indicate that future studies aiming to investigate the relationship 
between COMT haplotypes and pain phenotypes – and most likely other conditions in which 
epinephrine contributes to the pathophysiology of pathological states – need to be aware that 
stress and sex are important components of this relationship. In fact, the strongest 
association between HPS haplotype and pain was observed in the subgroup of males who 
reported no stress, which comprises the smallest subgroup analyzed (n = 331). In other 
words, in order to be able to identify the association of COMT haplotypes with a given 
phenotype or condition, one should ideally ensure that phenotypes are being collected within 
the linear range of this relationship, before such effects have already caused COMT 
dependent pain sensitivity to plateau (Figure 3). Further development of new statistical 
approaches are required that will allow to measure association between genetic variants and 
behavioral phenotypes in a dynamic manner rather than a static one.
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Figure 1. 
Average experimental thermal pain sensitivity for the measures of AUC at the temperatures 
of 46, 48, and 50°C in subjects reporting no stress (stress = 0), the fiftieth (stress = 10) or the 
seventy-fiftieth percentile (stress = 20) of stress ratings in females and males carrying 0, 1, 
or 2 copies of the HPS haplotype.
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Figure 2. 
Average acute pain sensitivity in low (PDI ≤ 18) or high stress (PDI >18) females and males 
carrying 0, 1, or 2 copies of the HPS haplotype. The dichotomization is defined by median 
split.
Meloto et al. Page 17
Pain. Author manuscript; available in PMC 2017 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. 
Summary of the inferences regarding the contribution of the COMT haplotype, stress, and 
sex to pain sensitivity. Both the HPS haplotype and stress lead to increased pain sensitivity 
that is sex-dependent, likely in an epinephrine-mediated manner. In both sexes, COMT-
dependent pain responses reach a plateau when stress reaches a certain level, although the 
plateau occurs at lower levels of stress in females compared to males. One implication is 
that, if COMT-dependent pain sensitivity is being investigated out of the linear range of the 
relationship between stress and pain, studies would not properly delineate the extent to 
which COMT haplotypes contribute to pain perception. The vertical dotted lines represent 
hypothesized conditions when association results have been assessed in the two cohorts for 
different stress levels.
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